Every open market buy and sale of Vaxcyte, Inc. stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $13.9M sold.
Buying and selling by month
open market, last 12 monthsGet an alert when PCVX insiders trade
We read every Form 4 the moment the SEC posts it and tell you when an PCVX officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.
Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.
Every PCVX insider trade
2 years · newest first| Insider | Type | Price | Held after | Filed | |||
|---|---|---|---|---|---|---|---|
| Nov 11, 2026 | Harpreet S. DhaliwalChief Technical Ops Officer | Sale plan | 17,000 | $67.83 | $1.2M | 68,085 | Nov 13Form 4 |
| Nov 2, 2026 | Jim WassilEVP, Chief Scientific Ofc, COO | Sale plan | 2,250 | $60.90 | $137K | 145,435 | Nov 4Form 4 |
| Nov 2, 2026 | Elvia CowanSVP, Finance & CAO | Sale plan | 3,000 | $60.92 | $183K | 27,860 | Nov 4Form 4 |
| Oct 5, 2026 | Jim WassilEVP, Chief Scientific Ofc, COO | Sale plan | 18,000 | $86.74 | $1.6M | 145,435 | Oct 7Form 4 |
| Oct 5, 2026 | Elvia CowanSVP, Finance & CAO | Sale plan | 19,000 | $86.74 | $1.6M | 27,860 | Oct 7Form 4 |
| Oct 1, 2026 | Jim WassilEVP, Chief Scientific Ofc, COO | Sale plan | 2,250 | $56.67 | $128K | 145,435 | Oct 2Form 4 |
| Sep 9, 2026 | Jim WassilEVP, Chief Scientific Ofc, COO | Sale | 2,715 | $60.35 | $164K | 145,435 | Sep 9Form 4 |
| Sep 1, 2026 | Jim WassilCOO | Sale | 3,477 | $61.07 | $212K | 155,041 | Sep 2Form 4 |
| Aug 5, 2026 | Harpreet S. DhaliwalChief Technical Ops Officer | Sale plan | 17,000 | $55.00 | $935K | 76,756 | Aug 5Form 4 |
| Aug 3, 2026 | Andrew GuggenhimePresident And CFO | Sale plan | 10,000 | $53.89 | $539K | 105,176 | Aug 5Form 4 |
| Aug 3, 2026 | Jim WassilCOO | Sale plan | 2,250 | $53.86 | $121K | 157,541 | Aug 5Form 4 |
| Jul 27, 2026 | Grant PickeringCEO | Sale plan | 18,198 | $55.63 | $1M | 133,215 | Jul 28Form 4 |
| Jul 6, 2026 | Andrew GuggenhimePresident And CFO | Sale plan | 10,000 | $57.28 | $573K | 104,395 | Jul 6Form 4 |
| Jul 1, 2026 | Jim WassilCOO | Sale plan | 2,250 | $56.33 | $127K | 156,760 | Jul 6Form 4 |
| Jun 26, 2026 | Grant PickeringCEO | Sale plan | 24,237 | $55.22 | $1.3M | 134,215 | Jun 26Form 4 |
PCVX insider trading FAQ
Are PCVX insiders buying or selling?
Insiders are only selling over the last 12 months. 0 insiders bought $0 of PCVX on the open market in 0 trades, and 5 sold $13.9M in 26 trades, 90% of that under pre-arranged trading plans.
When did an PCVX insider last buy shares?
There has been no open market insider purchase of PCVX in the last two years.
When did an PCVX insider last sell shares?
Harpreet S. Dhaliwal (Chief Technical Ops Officer) sold 17,000 shares for $1.2M on Nov 11, 2026, under a pre-arranged trading plan.
What is a Form 4?
Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.
Why do insider sales matter less than buys?
Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.
From SEC Form 4 filings · Not investment advice
